Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880503 · ClinicalTrials.gov registry record
Collection of Tissue Samples for Study of Multidrug Resistance
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 325
- Enrollment target
NCT00880503: Completed study, sponsored by National Cancer Institute (NCI).
NCT00880503 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 325 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00880503 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 325 participants
- Enrollment target
Study Summary
Background: Resistance to cancer chemotherapy develops in patients, rendering certain treatments ineffective. Despite much research, the prevailing cause of drug resistance is not known. One mechanism for drug resistance involves a protein called P-glycoprotein, or Pgp, which reduces the effectiveness of cancer treatments by "pumping" anti-cancer drugs out of tumor cells where they are supposed to work against the disease. Objectives: To identify and evaluate more thoroughly the roles of Pgp and other substances in mediating drug resistance. Eligibility: Patients enrolled in clinical trials of cancer therapies at the Children's Hospital of Pittsburgh; Cancer Centers of Carolinas; Arizona Clinical Research Center; University of Copenhagen; and Herlev Hospital, Copenhagen who have consented to the use of blood, tissue, or tumor samples for laboratory studies. Design: Blood, tumor, and tissue samples are collected from participants and sent to the NCI for various laboratory analyses. ...
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2003-12-19 |
| Est. Completion | 2018-02-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880503
The ClinicalTrials.gov registry entry for NCT00880503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00880503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880503 about?
NCT00880503 is a clinical study titled "Collection of Tissue Samples for Study of Multidrug Resistance". Background: Resistance to cancer chemotherapy develops in patients, rendering certain treatments ineffective. Despite much research, the prevailing cause of drug resistance is not known. One mechanism for drug resistance involves a protein called P-glycoprotein, or Pgp, which reduces the effective...
What is the current status of trial NCT00880503?
This trial is currently completed. The enrollment target is 325 participants. The study started on 2003-12-19. Estimated completion is 2018-02-08.
Who is sponsoring clinical trial NCT00880503?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.